RNTX
Rein Therapeutics Inc.
NASDAQ · USHealthcareMedical - Pharmaceuticals
$0.84-2.08%
Price as of Jul 20, 2026
RNTX earnings
Rein Therapeutics Inc. earnings
Reported EPS and revenue history, upcoming estimates and available earnings-call summaries.
Next earnings
Aug 13, 2026in NaN days
EPS est $-0.27 · Revenue est —
Track record
Beat EPS in 3 of 11 quarters
Avg surprise -90.5% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| May 15, 2026 | $-0.49 | $-0.19 | +61.2% | — | — |
| Mar 26, 2026 | $-0.24 | $-1.22 | -408.3% | — | — |
| Nov 14, 2025 | $-0.24 | $-0.21 | +12.5% | — | — |
| Aug 14, 2025 | $-0.22 | $-0.28 | -27.3% | — | — |
| Apr 7, 2025 | $-0.14 | $-0.26 | -85.7% | — | — |
| Dec 31, 2024 | $-0.46 | $-1.89 | -310.7% | — | — |
| Aug 14, 2024 | $-0.25 | $-0.45 | -80.0% | — | — |
| Mar 31, 2024 | $-0.14 | $-0.86 | -512.0% | — | — |
| Dec 31, 2023 | $-0.16 | $-1.54 | -840.0% | — | — |
| Sep 30, 2023 | $-0.20 | $-0.40 | -101.2% | — | — |
| Jun 30, 2023 | $-0.40 | $-0.39 | +1.6% | — | — |
Earnings history is derived from company filings and calendar data. Call summaries are grouped by reporting period. Latest covered event: 2026-08-13.